Abstract:Objective To investigate the changes of pulmonary vascular function early after ischemia-reperfusion injury in rats with lung transplantation, and determine the role of inducible nitric oxide synthase (iNOS) in the process. Methods Forty Sprague-Dawley rats weighing 300-400 g were allocated into two groups, control group (sham, n=10, only receiving thoractomy and ventilation), and lung transplant group (including 15 donors and 15 recipients). The model of rat orthotopic left lung allograft transplantation was established using the cuffs technique. After that, a 2-hour reperfusion was followed, and then the left lungs were resected. Wet-to-dry lung weight ratio (W/D), lung Evans blue contents, contents of myeloperoxidase (MPO) and malondialdehyde (MDA), and activities of iNOS and endothelial nitric oxide synthase (eNOS) were detected by biochemical methods. Isolated pulmonary artery rings were prepared. Ring responses were evaluated in the presence and absence of endothelium and non-selective nitric oxide synthase inhibitor (L-NAME, 300 μmol/L) or selective iNOS inhibitor (L-NIL, 10 μmol/L) incubation. Either vascular relaxation function or contraction function were tested by cumulative relaxation response curve to acetylcholine or cumulative contraction response curve to phenylephrine. Results The lung wet/dry ratio and Evans blue contents in lung transplant group were significantly higher than those in control group (5.18±0.45 vs. 4.33±0.41, [36.51±5.07] vs. [26.01±4.59] μg/mL, P<0.05). The contents of MDA and MPO and activity of iNOS in the lung transplant group were significantly higher than those in control group (P<0.05), but the eNOS activity was significantly lower (P<0.05). When compared with the control group, both relaxation and constriction function of the isolated pulmonary artery rings were impaired in the lung transplant group (P<0.05). When pretreated with L-NAME, contraction function in the control group were significantly stronger (P<0.05). Contraction function in the transplant group after L-NAME treatment was significantly stronger when compared with the transplant lung without L-NAME treatment (P<0.05), though having no difference with that of control group (P>0.05). Compared with the transplant group, the contraction function was strongly improved after L-NIL treatment (P<0.05). No difference was found in contraction function between the control group with or without L-NIL treatment, or between the L-NIL treated transplant group and the control group. Conclusion During reperfusion after lung transplantation, oxidative stress injury is aggravated, and pulmonary capillary permeability is increased. Both relaxation and contraction function of isolated pulmonary artery is damaged. The abnormally increased iNOS and decreased eNOS activity might contribute to the pulmonary vascular dysfunction after early reperfusion injury.

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

New strategies to reduce ischemia/reperfusion injury following lung allotransplantation by substitution of the NO/cGMP pathway

Nitroprusside Ameliorates Lung Allograft Reperfusion Injury.

The Nitric Oxide Synthase Cofactor Tetrahydrobiopterin Reduces Allograft Ischemia-Reperfusion Injury after Lung Transplantation.

Nitrite Reduces Acute Lung Injury and Improves Survival in a Rat Lung Transplantation Model

Nitrite attenuates mitochondrial impairment and vascular permeability induced by ischemia-reperfusion injury in the lung

Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury

Combined Treatment with Endothelin- and PAF-antagonists Reduces Posttransplant Lung Ischemia/reperfusion Injury.

Therapeutic benefits of nitric oxide in lung transplantation

Preharvest Nitroprusside Flush Improves Posttransplantation Lung Function.

Survival and Graft Function in A Large Animal Lung Transplant Model after 30 H Preservation and Substitution of the Nitric Oxide Pathway

Attenuation of lung graft reperfusion injury by a nitric oxide donor

Reduction of lung allograft ischemia/reperfusion injury by tetrahydrobiopterin coenzyme of NOS.

Role of inducible nitric oxide synthase in pulmonary vascular dysfunction in rats after lung transplantation

Inducible Nitric Oxide Synthase Inhibition Reverses Pulmonary Arterial Dysfunction in Lung Transplantation.

Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation

EFFECTS OF NITRIC OXIDE ON REPERFUSION INJURY FOLLOWING PANCREATICODUODENAL TRANSPLANTATION IN RATS

Effect of L-N6-(1-tminoethyl) Lysine on Ischemia-Reperfusion Injury in a Rat Model of Lung Transplantation

Protection against lung damage in reduced-size liver transplantation

N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation.

Investigation of the preventive effect of proanthocyanidin in ischemia-reperfusion injury in lung transplantation: An experimental study